HPLC, UHPLC
HPLC-MS used in cholesterol study
Aug 05 2011
In a study published in Lipids in Health and Disease, a team from the Department of Biomedical Science and Technology at the University of Cagliari in Italy analysed and compared cholesterol variations in extracts of ScN2a cells and in brains of scrapie-infected C57Bl/6 mice.
To do this, the scientists used two different methods - a fluorimetric-enzymatic cholesterol assay and HPLC-MS.
The team found that infected cells and brains showed cholesterol anomalies compared to non-infected cells, although only the HPLC-MS method highlighted statistically significant cholesterol variations, particularly in the cholesteryl esters (CE) fraction.
Oral pravastatin administration to scrapie-infected mice, was associated with a significant reduction of cerebral FC along with an attendant further increase of the CE pool.
The scientists claimed that although further studies are needed, this is the first report to provide evidence of higher levels of cholesterol esterification in brains of prion-infected mice, untreated and treated with pravastatin.
Digital Edition
Chromatography Today - Buyers' Guide 2022
October 2023
In This Edition Modern & Practical Applications - Accelerating ADC Development with Mass Spectrometry - Implementing High-Resolution Ion Mobility into Peptide Mapping Workflows Chromatogr...
View all digital editions
Events
May 15 2024 Birmingham, UK
May 19 2024 Brno, Czech Republic
May 21 2024 Lagos, Nigeria
May 23 2024 Beijing, China
May 28 2024 Tel Aviv, Israel